In the context of the current global COVID-19 pandemic, this Consensus Statement provides current recommendations for patients with, or at risk of developing, genetic heart disease, and for their health care management and service provision in Australia and New Zealand. Apart from general recommendations, there are specific recommendations for the following conditions: cardiomyopathy, Brugada syndrome (including in children), long QT syndrome (LQTS) and catecholaminergic polymorphic ventricular tachycardia (CPVT). Other recommendations are relevant to patient self-care and primary health care.

中文翻译：

---

遗传性心脏病和 COVID-19 患者：澳大利亚和新西兰心脏病学会 (CSANZ) 共识声明。

在当前全球 COVID-19 大流行的背景下，本共识声明为患有遗传性心脏病或有患遗传性心脏病风险的患者以及他们在澳大利亚和新西兰的医疗保健管理和服务提供提供了当前建议。除了一般建议外，还有针对以下情况的具体建议：心肌病、Brugada 综合征（包括儿童）、长 QT 综合征 (LQTS) 和儿茶酚胺能多形性室性心动过速 (CPVT)。其他建议与患者自我保健和初级保健有关。